Showing results (11-20 of 827) with videos related to
Sort By:
Pageof 83
P & T : a Peer-Reviewed Journal for Formulary Management|June 6, 2015
Dyslipidemia: blockbuster therapies are on the horizonRinki Patel, Kunj GohilP & T : a Peer-Reviewed Journal for Formulary Management|March 2, 2018
NIH Starts to Spend $4.8 Billion in "Extra" Cures Drug Research MoneyStephen BarlasP & T : a Peer-Reviewed Journal for Formulary Management|March 2, 2018
The 21st Century Cures Act: FDA Implementation One Year Later: Some Action, Some Results, Some QuestionsStephen BarlasP & T : a Peer-Reviewed Journal for Formulary Management|March 2, 2018
Expediting Formulary Standardization in a Multihospital Health System Using Layered LearnersAmanda J Hays, Jennifer R Smith, Rebecca M Guth, et al.P & T : a Peer-Reviewed Journal for Formulary Management|March 2, 2018
ASCO Gastrointestinal Cancers Symposium And San Antonio Breast Cancer SymposiumWalter AlexanderP & T : a Peer-Reviewed Journal for Formulary Management|February 2, 2018
Talk of a "Default" Drug Formulary Rattles Industry: CMS Could Move in That Direction for Marketplace Plans After 2019, but the Discussion Has Already StartedStephen BarlasP & T : a Peer-Reviewed Journal for Formulary Management|January 2, 2018
Pharmaceutical Approval UpdateMichele B KaufmanP & T : a Peer-Reviewed Journal for Formulary Management|January 2, 2018
Despite Gains, the War on HIV Is Far From Over: With No Cure in Sight, Experts Urge Early Diagnosis and Prompt Treatment With Better AdherenceSusan L WorleyP & T : a Peer-Reviewed Journal for Formulary Management|December 14, 2017
Bezlotoxumab (Zinplava) for Clostridium Difficile Infection: The First Monoclonal Antibody Approved to Prevent the Recurrence of a Bacterial InfectionYuman Lee, Wai I Lim, Caitlyn I Bloom, et al.P & T : a Peer-Reviewed Journal for Formulary Management|October 12, 2017
Pharmaceutical Approval UpdateMichele B KaufmanPageof 83